1312.HK
Price:
$0.028
Market Cap:
$156.05M
Kontafarma China Holdings Ltd. engages in the manufacture and sale of cement. It operates through the following segments: Pharmaceutical and Fitness Business. The Pharmaceutical Business segment involves in manufacture and sales of prescription drugs and laboratory related products. The Fitness Business segment includes the operation of fitness centers and provide consultation services for fitness and health activities and operate the franchise business for royalty fee income. The company was founded on March 21, 2011 and is headquartered in Hong Kong.
Industry
Construction Materials
IPO Date
2012-01-18
Stock Exchange
HKSE
Ticker
1312.HK
According to Kontafarma China Holdings Ltd’s latest financial reports and current stock price. The company's current ROE is -43.61%. This represents a change of 214.73% compared to the average of -13.86% of the last 4 quarters.
The mean historical ROE of Kontafarma China Holdings Ltd over the last ten years is -3.68%. The current -43.61% ROE has changed 1.08% with respect to the historical average. Over the past ten years (40 quarters), 1312.HK's ROE was at its highest in in the December 2010 quarter at 8.85%. The ROE was at its lowest in in the June 2025 quarter at -41.24%.
Average
-3.68%
Median
-2.78%
Minimum
-22.00%
Maximum
4.62%
Discovering the peaks and valleys of Kontafarma China Holdings Ltd ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 198.88%
Maximum Annual ROE = 4.62%
Minimum Annual Increase = -1680.78%
Minimum Annual ROE = -22.00%
| Year | ROE | Change |
|---|---|---|
| 2024 | -7.72% | 182.92% |
| 2023 | -2.73% | -27.70% |
| 2022 | -3.77% | 198.88% |
| 2021 | -1.26% | -94.26% |
| 2020 | -22.00% | -576.48% |
| 2019 | 4.62% | 97.99% |
| 2018 | 2.33% | -1680.78% |
| 2017 | -0.15% | -95.52% |
| 2016 | -3.29% | 16.16% |
| 2015 | -2.83% | -310.77% |
The current ROE of Kontafarma China Holdings Ltd (1312.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.74%
5-year avg
-7.50%
10-year avg
-3.68%
Kontafarma China Holdings Ltd’s ROE is greater than Ko Yo Chemical (Group) Limited (-179.93%), greater than Changmao Biochemical Engineering Company Limited (-13.19%), greater than Huajin International Holdings Limited (-393.60%), greater than Timeless Software Limited (-34.59%), greater than Greenheart Group Limited (-30.29%), greater than Lee Kee Holdings Limited (-3.69%), greater than PanAsialum Holdings Company Limited (-0.58%), greater than Future Bright Mining Holdings Limited (-42.11%), less than Diwang Industrial Holdings Limited (3.60%), greater than CPM Group Limited (-16.78%),
| Company | ROE | Market cap |
|---|---|---|
| -179.93% | $168.97M | |
| -13.19% | $150.91M | |
| -393.60% | $168.00M | |
| -34.59% | $139.13M | |
| -30.29% | $255.99M | |
| -3.69% | $129.28M | |
| -0.58% | $148.73M | |
| -42.11% | $222.27M | |
| 3.60% | $118.08M | |
| -16.78% | $160.00M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kontafarma China Holdings Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kontafarma China Holdings Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Kontafarma China Holdings Ltd's ROE?
How is the ROE calculated for Kontafarma China Holdings Ltd (1312.HK)?
What is the highest ROE for Kontafarma China Holdings Ltd (1312.HK)?
What is the 3-year average ROE for Kontafarma China Holdings Ltd (1312.HK)?
What is the 5-year average ROE for Kontafarma China Holdings Ltd (1312.HK)?
How does the current ROE for Kontafarma China Holdings Ltd (1312.HK) compare to its historical average?